DENMARK - Nordic Phytopharma A/S is sold to Scandinavian Clinical Nutrition AB

Scandinavian Clinical Nutrition AB (SCN) has acquired Nordic Phytopharma, a Danish pharmaceutical business and Biolink Capital portfolio company, for SEK 60m including an earn-out. SCN will pay for the pharmaceutical in cash and shares. The acquisition gives Scandinavian Clinical Nutrition access to two patented products within immune system boosting and the treatment of the common cold. The acquisition will also strengthen SCN's export activities to Europe, Asia and South America